Invention Grant
- Patent Title: Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
-
Application No.: US15307766Application Date: 2015-04-22
-
Publication No.: US10596387B2Publication Date: 2020-03-24
- Inventor: Harold Walder , Frederic A. Bourke , Zakaryae Fathi , Wayne F. Beyer , Mark W. Dewhirst , Mark Oldham , Justus Adamson , Michael Nolan
- Applicant: IMMUNOLIGHT, LLC. , DUKE UNIVERSITY
- Applicant Address: US MI Detroit US NC Durham
- Assignee: IMMUNOLIGHT, LLC.,DUKE UNIVERSITY
- Current Assignee: IMMUNOLIGHT, LLC.,DUKE UNIVERSITY
- Current Assignee Address: US MI Detroit US NC Durham
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- International Application: PCT/US2015/027058 WO 20150422
- International Announcement: WO2015/164485 WO 20151029
- Main IPC: A61N5/06
- IPC: A61N5/06 ; A61N5/10 ; A61N5/02 ; A61K49/04 ; A61K41/00 ; A61K39/00

Abstract:
A system and method for imaging or treating a disease in a human or animal body. The system provides to the human or animal body a pharmaceutical carrier including one or more phosphors which are capable of emitting ultraviolet or visible light into the body and which provide x-ray contrast. The system includes one or more devices which infuse a diseased site with a photoactivatable drug and the pharmaceutical carrier, an initiation energy source comprising an x-ray or high energy source which irradiates the diseased site with at least one of x-rays, gamma rays, or electrons to thereby initiate emission of said ultraviolet or visible light into the body, and a processor programmed to at least one of 1) produce images of the diseased site or 2) control a dose of said x-rays, gamma rays, or electrons to the diseased site for production of said ultraviolet or visible light at the diseased site to activate the photoactivatable drug.
Public/Granted literature
Information query